Breast implant removal surgery, often called explant surgery, removes breast implants and, when appropriate, the capsule of scar tissue that surrounds them. Four distinct surgical techniques address different capsule findings, anatomy, and clinical goals.
Robert Whitfield, MD, has performed more than 2,000 explant procedures and published the largest PCR analysis of breast implant capsules in the medical literature. His research and surgical experience inform an individualized approach to implant and capsule removal.
Explant Procedures
Capsules PCR-Tested
Contamination Identified
Bacterial Species Identified
Breast implant removal surgery is the surgical removal of one or both breast implants. The operation may also address the capsule, a layer of scar tissue that the body naturally forms around every implant.
Capsule formation is expected. The clinical questions are whether the capsule is thin and healthy or thickened, calcified, contracted, ruptured, or potentially contaminated. A patient seeking a cosmetic reversal after an uncomplicated implant history may not require capsule removal. A patient with breast implant illness concerns, capsular contracture, silicone rupture, or an implant-associated condition may need a more complete operation.
Explant surgery and breast implant removal are two names for the same category of operation. The meaningful distinction is how the capsule is managed. That decision determines what tissue is removed and what remains.
For several years, Dr. Whitfield has incorporated planned preoperative deflation into the evaluation of selected patients with saline implants. The saline is removed before the scheduled operation, allowing the breast to be reassessed without implant volume while the deflated implant shell remains in place until surgery.
Review the published study, PMID 26038371 →Removing the saline volume can give the patient and surgeon a closer look at the natural breast tissue, skin envelope, and asymmetry before the definitive operation. It is a planning preview, not a promise, and it does not predict an exact surgical result.
Reassessment after deflation may help clarify whether implant removal alone, a breast lift, fat transfer, or a combined plan best fits the patient's anatomy and goals. The final choice still requires an individualized examination and informed consent.
A retrospective review included 55 patients undergoing 57 revisional surgeries. In the published protocol, saline implants were deflated 4 weeks before revision and patients were reassessed after 3 weeks. In the 10-patient subset evaluated with 3D imaging, mean breast volume increased 15.2% and mean notch-to-nipple distance decreased 0.18 cm after deflation. The authors reported that deflation may reveal glandular volume and simplify mastopexy markings for revisional planning. It does not guarantee a simpler procedure or a particular outcome.
Important: planned deflation applies to saline implants only, not silicone implants, and it is not offered automatically. Candidacy and timing depend on implant information, examination, imaging when indicated, tissue quality, surgical goals, and the patient's comfort with the temporary deflated appearance before surgery.
The word explant does not identify how the capsule will be handled. Each technique serves a different purpose, and more extensive surgery is not automatically better surgery.
The implant is removed while the capsule is left in place. This is the least extensive option and can be appropriate when the capsule is thin, soft, healthy, and unaffected by rupture or contracture.
What is removed: The implant only.
Often considered for: Healthy capsules and straightforward aesthetic reversals when capsule removal is not clinically indicated.
The surgeon removes the implant and selected portions of the capsule, including tissue that is thickened, calcified, or otherwise concerning. Capsule adherent to critical structures may be left when safety requires it.
What is removed: The implant and part of the capsule.
Often considered for: Cases in which abnormal capsule tissue should be removed but complete removal would create disproportionate risk.
The entire capsule is removed, although it may be taken out in more than one piece. A meticulous total capsulectomy can provide complete capsule removal without requiring a single sealed specimen.
What is removed: The implant and the entire capsule.
Often considered for: Many patients with breast implant illness concerns, capsular contracture, or a goal of complete capsule removal.
The implant remains enclosed while the entire capsule is removed as one intact unit. This is the most technically demanding approach and is reserved for anatomy and indications that support it.
What is removed: The implant and capsule as one sealed specimen.
Often considered for: Clinical situations in which preventing capsule contents from entering the surgical field is important.
| Technique | Implant | Capsule | Typical clinical role |
|---|---|---|---|
| Simple removal | Removed | Left in place | Healthy capsule and cosmetic reversal |
| Partial capsulectomy | Removed | Partially removed | Selected abnormal capsule tissue |
| Total capsulectomy | Removed | Completely removed | BII concerns, contracture, complete removal goals |
| En bloc capsulectomy | Removed | Removed as a sealed specimen | Selected rupture or malignancy-related indications |
The central distinction: total capsulectomy and en bloc capsulectomy can both remove the entire capsule. En bloc removal keeps the specimen sealed in one piece. The safest plan is the technique supported by anatomy, imaging, implant condition, and clinical indication rather than a one-technique promise.
A capsule is not always inert scar tissue. Bacterial biofilm can be present without a visible sign in the operating room, making capsule evaluation and pathology relevant to surgical planning.
Review the published study on PubMed →Dr. Whitfield and colleagues analyzed 694 breast implant capsule specimens with polymerase chain reaction testing. Bacterial contamination was identified in 29 percent of specimens, with 103 distinct bacterial species represented across the dataset.
The study was published in Microorganisms and indexed as PMID 39338504. These findings support a more informed discussion of capsule management, particularly for patients with breast implant illness concerns or chronic inflammatory symptoms.
Technique names describe how tissue is removed. Research helps explain why capsule tissue may deserve careful evaluation. The final plan still depends on the individual patient's anatomy, symptoms, imaging, implant condition, and operative safety.
A thin, healthy capsule without rupture or contracture can support a less extensive removal when the goal is a straightforward return to a natural breast.
Many patients with BII concerns or capsular contracture can receive complete capsule removal through total capsulectomy. This approach allows the entire capsule to be removed without forcing a single-piece dissection when anatomy does not support it safely.
An intact, sealed specimen can be important for selected silicone ruptures and suspected or confirmed BIA-ALCL. The additional technical demand is justified when the clinical situation requires containment.
Breast implant removal is not priced as a single standardized operation. The individualized quote reflects the technique, capsule findings, facility resources, anesthesia, and any natural restoration procedure included in the plan.
Simple removal and complete capsulectomy require different operative planning. Rupture, calcification, contracture, and adherence to surrounding structures can also change complexity.
Facility resources, operating-room support, pathology handling, and safety systems are part of the individualized surgical plan.
Anesthesia is administered by a Certified Registered Nurse Anesthetist as part of the accredited surgical team.
A breast lift, fat transfer, or BodyTite skin tightening changes the scope of the operation and is quoted only when it is part of the patient's chosen plan.
A consultation produces a specific, itemized quote based on the final surgical plan. Financing options are available through the practice.
After implant removal, the remaining breast tissue is no longer supported by implant volume. Breasts commonly appear smaller and softer, and skin may reflect the stretch created by the prior implants.
Appearance varies according to natural breast tissue, implant size, implant position, skin elasticity, capsule condition, and whether a lift or fat transfer is part of the operation. Early appearance is not treated as a final result because tissue continues to settle through the individualized healing process.
Implant removal does not require giving up on breast shape. Natural restoration can address volume, skin laxity, and contour without placing another breast implant.
Mastopexy removes excess skin and repositions breast tissue for a firmer shape when anatomy and tissue quality support a lift.
Fat harvested from another area of the body can restore breast volume with the patient's own tissue while also contouring the donor area.
Explore fat transfer →Selected patients can combine fat transfer with bipolar radiofrequency skin tightening to address volume and the skin envelope in one individualized plan.
Recovery guidance is individualized to the removal technique, capsule dissection, added procedures, clinical findings, and the patient's broader health needs. Activity, incision care, symptom monitoring, and follow-up are reviewed directly by the surgical team.
The SHARP Method, or Strategic Holistic Accelerated Recovery Program, is Dr. Whitfield's functional-medicine framework for reducing inflammatory burden and supporting healing around surgery.
For a patient seeking removal because of breast implant illness, the operation addresses the implants and capsule while the recovery framework addresses the wider inflammatory and metabolic context. The plan is adapted to clinical findings rather than delivered as a fixed schedule.
Insurance coverage is sometimes available when a carrier considers removal medically necessary. Commonly reviewed indications include documented capsular contracture, implant rupture, infection, and certain implant-associated conditions.
Cosmetic removal and many breast implant illness cases may be classified as elective. Coverage differs across carriers and plans, and the insurer determines the documentation and benefits available to each patient.
There is no procedural difference. Explant surgery is the common patient term, while breast implant removal is the literal description. Both refer to removing breast implants and, when indicated, the surrounding capsule.
No. Capsule management depends on clinical findings. A healthy capsule in a cosmetic reversal may be left in place, while contracture, contamination concerns, rupture, or certain implant-associated conditions may support partial or complete capsule removal.
En bloc capsulectomy removes the implant and the entire capsule together as one sealed specimen. It is considered when keeping the capsule sealed is clinically important, including certain ruptures and suspected or confirmed implant-associated malignancy. Many other cases can be addressed with total capsulectomy.
Coverage is sometimes available when an insurer determines that removal is medically necessary, such as documented capsular contracture, rupture, infection, or another covered implant-related condition. Benefits vary by carrier and plan.
Surgical duration depends on the removal technique, capsule findings, anatomy, and whether a lift, fat transfer, or skin-tightening procedure is included. The surgical team estimates the plan after the clinical evaluation.
Breasts commonly look smaller and softer after implant removal. Final appearance depends on natural breast tissue, implant size, skin elasticity, capsule condition, and whether a lift, fat transfer, or skin tightening is included.
For a selected patient with saline implants, planned deflation before surgery can provide a closer preview of her natural breast tissue without implant volume and give the tissue time to recoil before reassessment. This may help refine the plan for removal alone, a breast lift, fat transfer, or a combined procedure. It does not predict an exact surgical result, applies only to saline implants, and is not offered automatically.
Yes. In appropriate candidates, a breast lift can be combined with implant removal to address stretched skin and reposition breast tissue. Suitability depends on anatomy, tissue quality, and surgical goals.
Cost is affected by surgeon experience, facility resources, CRNA anesthesia, removal technique, capsule complexity, and any added procedure such as a breast lift or fat transfer. Each patient receives an individualized, itemized quote after consultation.
Not inherently. Both can remove the entire capsule. En bloc capsulectomy keeps the capsule sealed in one specimen, while total capsulectomy can remove it in more than one piece. Safety depends on anatomy, implant condition, and selecting the technique that fits the clinical indication.
The SHARP Method, or Strategic Holistic Accelerated Recovery Program, is Dr. Whitfield's whole-patient framework for reducing inflammatory burden and supporting surgical healing. It is individualized around clinical findings and the patient's health needs.
Dr. Whitfield's practice is based in Austin, Texas, and welcomes patients from throughout the United States and internationally. Travel and scheduling coordination support patients coming to Austin for evaluation and surgery.
Dr. Robert Whitfield has guided thousands of patients through surgical decisions with clarity, data, and a personalized plan. Your consultation is where that plan begins.
Not ready to book? Download the free Inflammation Support Guide to start your journey.